AIP
TWST icon

Arrowpoint Investment Partners’s Twist Bioscience TWST Stock Holding History

Arrowpoint Investment Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
20,287
+6,811
+51% +$443K 0.45% 38
2026
Q1 		$640K Buy
13,476
+3,484
+35% +$156K 0.57% 33
2025
Q4 		$317K Buy
+9,992
New +$312K 0.05% 85

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Arrowpoint Investment Partners's TWST Position: Q2 2026 in Review

Arrowpoint Investment Partners increased its Twist Bioscience (TWST) stake by 51% in Q2 2026, buying an estimated $443K and bringing the position to 20,287 shares worth $2.09M. The position accounts for 0.45% of the portfolio, ranked #38.

Arrowpoint Investment Partners first reported a position in TWST in Q4 2025 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Arrowpoint Investment Partners held 20,287 shares of Twist Bioscience worth $2.09M as of Q2 2026.
  • Arrowpoint Investment Partners bought 6,811 Twist Bioscience shares in Q2 2026, an estimated $443K.
  • Twist Bioscience made up 0.45% of Arrowpoint Investment Partners's portfolio in Q2 2026, its #38 holding.
  • Arrowpoint Investment Partners first reported a position in Twist Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.